BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

MDS Diagnostic Services (MDZ) Completes Sale Of Interest In Calgary Laboratory Services Partnership


4/4/2006 11:40:27 AM

TORONTO, April 4 /PRNewswire-FirstCall/ - MDS Diagnostic Services, a leading provider of laboratory testing and management services in Canada and a subsidiary of MDS Inc. , announced the sale of its interest in the Calgary Laboratory Services partnership to the Calgary Health Region, effective April 3, 2006.

Under the terms of the agreement, the Calgary Health Region purchased MDS's 25% interest in Calgary Laboratory Services for $21.4 million. The business, which was moved into discontinued operations during the fourth quarter of 2005, generated approximately $70 million in revenues and $1.5 million in net income in 2005. MDS Inc. will record this sale in the second quarter ending April 30, 2006.

MDS Diagnostic Services, a business unit of MDS Inc., is a leading provider of laboratory testing and management services. MDS Inc. is a global life sciences company that provides market-leading products and services that our customers need for the development of drugs and diagnosis and treatment of disease. We are a leading global provider of pharmaceutical contract research, medical isotopes for molecular imaging, radiotherapeutics, and analytical instruments. MDS has more than 8,800 highly skilled people in 28 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24 hours a day.

This document contains forward-looking statements. Some forward-looking statements may be identified by words like "expects", "anticipates", "plans", "intends", "indicates" or similar expressions. The statements are not a guarantee of future performance and are inherently subject to risks and uncertainties. The Company's actual results could differ materially from those currently anticipated due to a number of factors, including, but not limited to, successful integration of structural changes, including restructuring plans, acquisitions, technical or manufacturing or distribution issues, the competitive environment for the Company's products, the degree of market penetration of the Company's products, and other factors set forth in reports and other documents filed by the Company with Canadian and US securities regulatory authorities from time to time.

MDS Inc.

CONTACT: Investor Contact: Sharon Mathers, Vice-President, InvestorRelations, (416) 675-6777 ext. 2695, smathers@mdsintl.com; Media Contact:Norm Berberich, Senior Manager, Communications, (416) 675-6777 ext. 2800,nberberich@mdsintl.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->